Ayako Nakashoji
Chuo, 1040045, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Prognosis of patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, 1-3 node-positive breast cancer meeting the high-risk criteria of the monarchE trial: a comparison between macrometastasis and micrometastasis.
Journal: Breast cancer (Tokyo, Japan)
Published: December 27, 2025
MUCIN 1 confers inflammatory memory of tyrosine kinase inhibitor resistance in non-small cell lung cancer.
Journal: Signal transduction and targeted therapy
Published: September 27, 2025
Emerging advances in non-surgical ablation for early-stage breast cancer.
Journal: Japanese journal of radiology
Published: September 02, 2025
Evaluation of progesterone receptors with different cutoff values according to menopausal status in hormone-positive early breast cancer.
Journal: Scientific reports
Published: May 01, 2025
Activation of APOBEC3 cytidine deaminases and endogenous retroviruses is integrated by MUC1-C in NSCLC cells.
Journal: Cell death discovery
Published: February 15, 2025
Corrigendum to 'MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC' [Journal of Thoracic Oncology 19 Issue 3 (2024) 434-450].
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 18, 2024
MUC1-C Dependence for the Progression of Pancreatic Neuroendocrine Tumors Identifies a Druggable Target for the Treatment of This Rare Cancer.
Journal: Biomedicines
Published: May 23, 2024
Tubular Carcinoma of the Breast: The Possibility to Omit Sentinel Lymph Node Biopsy.
Journal: Cancer diagnosis & prognosis
Published: February 27, 2024
Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas.
Journal: Cancer research communications
Published: January 09, 2024
Last Updated: 09/26/2026